Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications
CONFIDENTIAL
1 other identifier
observational
512
1 country
1
Brief Summary
Aim of this study is to proof the efficacy of in Jena established prophylaxis of new bone formation aside the skeleton with irradiation and compare it with the common literature. Furthermore we want to compare irradiation treatment with the alternative prophylaxis with analgetics from the NSAID type.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
January 22, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedFebruary 9, 2024
February 1, 2024
11 years
January 22, 2024
February 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of heterotopic ossification (HO)
X-ray controlled HO diagnostics with the Brooker classification
at least 365 days postoperative
Study Arms (2)
Intervention group with prophylactic irradiation
Patients with total hip arthroplasty and irradiation (preoperative on the day before the operation (\>24h preoperative)) Quantity: 128 Period: 01.01.2013 - 31.12.2023
Control group with prophylactic NSAID-treatment
Patients with total hip arthroplasty and diclofenac treatment Quantity: 384 Period: 01.01.2013 - 31.12.2023
Interventions
postoperative treatment with diclofenac to prevent HO
Eligibility Criteria
All participants of the study are patients at the Universitätsklinikum Jena or the Waldkrankenhaus Eisenberg. Irradiation was performed in Jena. Total hip arthoplasty and following inpatient stay, inclusive NSAID therapy was performed in Eisenberg
You may qualify if:
- Patients with total hip arthroplasty performed at Eisenberg Patients with preoperative irradiation (24h pre-op) or postoperative diclofenac treatment Patients with x-ray images immediately (3-5 days postoperative) postoperative and at least 365 days postoperative
You may not qualify if:
- Patients with missing follow up image
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Radiooncology, Jena
Jena, 07743, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Matthias Mäurer, Dr.
Klinik für Strahlentherapie und Radioonkologie des Universitätsklinikums Jena
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 22, 2024
First Posted
February 9, 2024
Study Start
January 1, 2013
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share